Patents Assigned to IPS BIO, INC.
  • COMPOSITION FOR PREVENTING AND TREATING STROKE, COMPRISING HLA HOMOZYGOUS INDUCED PLURIPOTENT STEM CELL-DERIVED NEURAL PRECURSOR CELLS
    Publication number: 20240252547
    Abstract: A pharmaceutical composition for preventing or treating a stroke, the pharmaceutical composition comprising, as an active ingredient, neural precursor cells differentiated from HLA homozygous human induced pluripotent stem cells (hiPSC-NPC), wherein, through the use of a homozygous type, immunorejection may be eliminated and stable therapeutic effects for stroke may be exhibited.
    Type: Application
    Filed: May 26, 2022
    Publication date: August 1, 2024
    Applicants: CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, IPS BIO, INC.
    Inventor: Jihwan SONG